propranolol has been researched along with Bone Loss, Osteoclastic in 15 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyproline excretion was increased by hyperthyroid patients." | 9.05 | [Effects of propranolol and indomethacin upon urinary hydroxyproline in hyperthyroid patients (author's transl)]. ( Benzoni, D; Beylot, M; Bodson, A; Mornex, R; Riou, JP; Vincent, M, 1982) |
| "Low doses of propranolol suppress bone resorption by inhibiting RANKL-mediated osteoclastogenesis as well as inflammatory markers without affecting haemodynamic parameters." | 5.38 | Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. ( Barbosa-Neto, O; Clemente-Napimoga, JT; da Silva, TA; Dias-da-Silva, VJ; Lopes, AH; Madeira, MF; Miguel, CB; Napimoga, MH; Rodrigues, WF, 2012) |
| "The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups." | 5.26 | Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982) |
| "Hydroxyproline excretion was increased by hyperthyroid patients." | 5.05 | [Effects of propranolol and indomethacin upon urinary hydroxyproline in hyperthyroid patients (author's transl)]. ( Benzoni, D; Beylot, M; Bodson, A; Mornex, R; Riou, JP; Vincent, M, 1982) |
| "Low doses of propranolol suppress bone resorption by inhibiting RANKL-mediated osteoclastogenesis as well as inflammatory markers without affecting haemodynamic parameters." | 1.38 | Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. ( Barbosa-Neto, O; Clemente-Napimoga, JT; da Silva, TA; Dias-da-Silva, VJ; Lopes, AH; Madeira, MF; Miguel, CB; Napimoga, MH; Rodrigues, WF, 2012) |
| "Propranolol-treated animals drank significantly less water, but did not differ in daily chow consumption or body weight gain." | 1.37 | The effects of systemic chemical sympathectomy on local bone loss induced by sciatic neurectomy. ( Chen, HI; Huang, TH; Lin, HS; Yang, RS, 2011) |
| "placebo, P = 0." | 1.35 | Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. ( Benhamou, CL; Bonnet, N; Courteix, D; Eder, V; Goncalves, C; Malaval, L; Pichon, C; Vico, L, 2008) |
| "The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups." | 1.26 | Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Treyball, A | 1 |
| Bergeron, AC | 1 |
| Brooks, DJ | 1 |
| Langlais, AL | 1 |
| Hashmi, H | 1 |
| Nagano, K | 1 |
| Barlow, D | 1 |
| Neilson, RJ | 1 |
| Roy, TA | 1 |
| Nevola, KT | 1 |
| Houseknecht, KL | 1 |
| Baron, R | 1 |
| Bouxsein, ML | 1 |
| Guntur, AR | 1 |
| Motyl, KJ | 1 |
| Uchibori, S | 1 |
| Sekiya, T | 1 |
| Sato, T | 2 |
| Hayashi, K | 1 |
| Takeguchi, A | 1 |
| Muramatsu, R | 1 |
| Ishizuka, K | 1 |
| Kondo, H | 1 |
| Miyazawa, K | 1 |
| Togari, A | 2 |
| Goto, S | 2 |
| Baek, K | 2 |
| Hwang, HR | 1 |
| Park, HJ | 1 |
| Kwon, A | 1 |
| Qadir, AS | 1 |
| Baek, JH | 1 |
| Ortuño, MJ | 1 |
| Robinson, ST | 1 |
| Subramanyam, P | 1 |
| Paone, R | 1 |
| Huang, YY | 1 |
| Guo, XE | 1 |
| Colecraft, HM | 1 |
| Mann, JJ | 1 |
| Ducy, P | 1 |
| Bonnet, N | 2 |
| Benhamou, CL | 2 |
| Malaval, L | 1 |
| Goncalves, C | 1 |
| Vico, L | 2 |
| Eder, V | 1 |
| Pichon, C | 1 |
| Courteix, D | 2 |
| Arai, M | 1 |
| Huang, TH | 1 |
| Lin, HS | 1 |
| Chen, HI | 1 |
| Yang, RS | 1 |
| Rodrigues, WF | 1 |
| Madeira, MF | 1 |
| da Silva, TA | 1 |
| Clemente-Napimoga, JT | 1 |
| Miguel, CB | 1 |
| Dias-da-Silva, VJ | 1 |
| Barbosa-Neto, O | 1 |
| Lopes, AH | 1 |
| Napimoga, MH | 1 |
| Bloomfield, SA | 1 |
| sseur, R | 1 |
| Sabatier, JP | 1 |
| Potrel-Burgot, C | 1 |
| Lecoq, B | 1 |
| Creveuil, C | 1 |
| Marcelli, C | 1 |
| Laroche, N | 1 |
| Dolleans, E | 1 |
| Beylot, M | 1 |
| Vincent, M | 1 |
| Benzoni, D | 1 |
| Bodson, A | 1 |
| Riou, JP | 1 |
| Mornex, R | 1 |
| Pizzarelli, F | 1 |
| Zoccali, C | 1 |
| Ciccarelli, C | 1 |
| Maggiore, Q | 1 |
| Bonucci, E | 1 |
| Ballanti, P | 1 |
| Dietrich, JW | 1 |
| Mundy, GR | 1 |
| Raisz, LG | 1 |
| Herrmann-Erlee, MP | 1 |
1 trial available for propranolol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
[Effects of propranolol and indomethacin upon urinary hydroxyproline in hyperthyroid patients (author's transl)].
Topics: Adult; Aged; Bone Resorption; Calcium; Female; Humans; Hydroxyproline; Hyperthyroidism; Indomethacin | 1982 |
14 other studies available for propranolol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Propranolol Promotes Bone Formation and Limits Resorption Through Novel Mechanisms During Anabolic Parathyroid Hormone Treatment in Female C57BL/6J Mice.
Topics: Animals; Bone and Bones; Bone Resorption; Female; Humans; Mice; Mice, Inbred C57BL; Osteoblasts; Ost | 2022 |
Suppression of tooth movement-induced sclerostin expression using β-adrenergic receptor blockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bone Morphogenetic Proteins; Bone Remodeling; Bone R | 2020 |
Propranolol, a β-adrenergic antagonist, attenuates the decrease in trabecular bone mass in high calorie diet fed growing mice.
Topics: Adrenergic Antagonists; Animals; Body Weight; Bone Density; Bone Marrow Cells; Bone Resorption; Diet | 2014 |
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.
Topics: Adrenergic beta-Antagonists; Animals; Bone and Bones; Bone Remodeling; Bone Resorption; Calcium; Flu | 2016 |
Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions.
Topics: Adrenergic beta-Antagonists; Animals; Biomechanical Phenomena; Blood Pressure; Bone Density; Bone Re | 2008 |
Effects of propranolol on bone metabolism in spontaneously hypertensive rats.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bone D | 2010 |
The effects of systemic chemical sympathectomy on local bone loss induced by sciatic neurectomy.
Topics: Activating Transcription Factor 4; Adrenergic beta-Antagonists; Animals; Bone and Bones; Bone Diseas | 2011 |
Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.
Topics: Acid Phosphatase; Alveolar Bone Loss; Animals; Bone Resorption; Cathepsin K; Cell Differentiation; C | 2012 |
Blocking β-adrenergic signaling attenuates reductions in circulating leptin, cancellous bone mass, and marrow adiposity seen with dietary energy restriction.
Topics: Adaptation, Physiological; Adipocytes; Adiposity; Adrenergic beta-Antagonists; Animals; Biomarkers; | 2012 |
Sympathetic nervous system as transmitter of mechanical loading in bone.
Topics: Absorptiometry, Photon; Adrenergic beta-Antagonists; Animals; Biomechanical Phenomena; Bone and Bone | 2003 |
Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Dose-Response Relationship, Drug; Female; Fe | 2006 |
Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
Topics: Bone Resorption; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Seco | 1982 |
Inhibition of bone resorption in tissue culture by membrane-stabilizing drugs.
Topics: Animals; Bone and Bones; Bone Resorption; Calcium; DNA; Fetus; Kinetics; Lidocaine; Parathyroid Horm | 1979 |
The effects of dibutyryl cyclic AMP, aminophylline and propranolol on PTE-induced bone resorption in vitro.
Topics: Aminophylline; Animals; Bone and Bones; Bone Resorption; Bucladesine; Calcium; Dose-Response Relatio | 1974 |